Clinical Trial Details


Research Study Summary

Midwest Chest Consultants, located in St. Charles Missouri, is currently conducting a research study with individuals with Chronic Obstructive Pulmonary Disease (COPD).


The study can last up to 58 weeks and can require up to 8 office visits and one follow-up telephone call. At each visit, the safety and effectiveness of the study medication will be monitored. Additionally, compensation for time and travel may be provided.

Patient Inclusion Criteria:

  • Are at least 40 years of age.
  • Have been diagnosed with COPD
  • Have experienced at least two COPD exacerbations (flare-ups) within the previous 12 months that caused you to seek medical attention.
  • Are a current or former smoker

Patient Exclusion Criteria:

  • Current diagnosis of asthma
  • History of suicidal behavior within the last two years.
  • Morbid Obesity
  • Alcohol or drug abuse within the last five years
  • History (within the last 5 years) or current diagnosis of cancer

To Learn more

CW ID: 180674
Date Last Changed: July 19, 2013

Clinical Trial Snapshot

Both Male and Female
40 and up
Overall Status
58 Weeks
Facility Type


Mitchell Champagne RPh, CCRC, Research Director
Midwest Chest Consultants, PC
330 First Capitol Drive
Suite 470
St. Charles, MO 63301
Phone: 636-946-1650

View Map

Research Center Information:

Midwest Chest Consultants, PC

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.